Nootropic peptides represent a unique category: compounds that enhance cognitive function, protect neurons, and in some cases produce rapid antidepressant-like effects. Russian medical research has been leading this field for decades, with Semax and Selank both achieving prescription status in Russia.
Tier 1: Strongest Evidence (Clinical Data)
Semax (and N-Acetyl Semax Amidate): A 7-amino acid synthetic peptide from ACTH 4-7. Significantly increases BDNF in the brain within 60 minutes of intranasal administration. Used clinically in Russia for stroke recovery and cognitive decline. N-Acetyl Semax Amidate is 2-3x more potent with better stability.
Selank (and NA-Selank Amidate): Derived from tuftsin with anxiolytic and nootropic properties. Has been in clinical use in Russia for generalized anxiety disorder. More calming and less stimulating than Semax.
Cerebrolysin: Porcine brain-derived neuropeptide mixture with the most robust clinical evidence in the class — multiple RCTs for Alzheimer's disease and traumatic brain injury. Requires IV or IM administration.
Tier 2: Promising Preclinical Data
Dihexa (PNB-0408): Angiotensin IV-derived peptide reported to be millions of times more potent than BDNF at forming new synaptic connections. Promotes dendritic spine growth via HGF/c-Met. Oral and sublingual bioavailability. However, human data is essentially absent — all evidence comes from animal models.
P21 Peptide: CNTF-derived peptide that increases BDNF production and enhances synaptic plasticity. Studied for Alzheimer's. Injectable.
PE-22-28: TREK-1 potassium channel antagonist producing rapid antidepressant effects (within 4 days in mouse models) — far faster than SSRIs. Intranasal delivery.
Tier 3: Limited Data
Noopept (GVS-111): A synthetic dipeptide often called 1000x more potent than piracetam. Increases acetylcholine sensitivity and BDNF expression. Oral bioavailability is reasonable. Widely used but lacks clinical trial data.
Pinealon: Khavinson tetrapeptide targeting the cerebral cortex and pineal gland. Studied for age-related cognitive decline and circadian dysregulation.
Semax vs Selank: The Key Distinction
These two are often compared because both are Russian peptide nootropics administered intranasally:
- Semax is stimulating. Better for focus, motivation, productivity, learning. Can cause anxiety in some at higher doses. Better in the morning.
- Selank is calming. Better for anxiety reduction, stress management, and improved learning under stress. More similar to an anxiolytic than a stimulant.
Some protocols use both — Selank in the morning, Semax mid-day — to combine anxiolytic and cognitive-enhancing effects.
Key Takeaways
For evidence-based nootropic peptides, Semax and Selank are the top choices with actual clinical data. Cerebrolysin is the most clinically validated but requires injection. Dihexa shows extraordinary preclinical promise but has no human data. All intranasal peptides should use standard insulin syringes converted to nasal droppers for accurate dosing.